Vectura Group Share Price (VEC)

172.00 -3.60 (-2.05%) delayed: 1:47PM BST
Bid price 172.00 Open price 173.10
Ask price 172.10 Prev close 172.00
High price 175.00 Spread 0.06%
Low price 170.80 Volume 1,583,972

Register now for FREE live Vectura Group share prices, Vectura Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Vectura Group Level 2 Data, indepth research tools and investor commentary for Vectura Group (VEC) and other London Stock Exchange equities.

Vectura Group Share Price Chart

Advanced Charts >>

Register now for FREE Vectura Group share price charts

Vectura Group Share Price Information

Name Vectura Group Epic VEC
Sector Pharmaceuticals & Biotechnology ISIN GB00B01D1K48
Activites Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura's main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25bn. Vectura has seven products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development, a number of which have been licensed to major pharmaceutical companies. Vectura has development collaborations and licence agreements with several pharmaceutical companies, including Novartis, Sandoz (the generics arm of Novartis), Baxter and GlaxoSmithKline (GSK). Vectura seeks to develop certain programmes itself where this will optimise value. Vectura's formulation and inhalation technologies are available to other pharmaceutical companies on an out-licensing basis where this complements Vectura's business strategy. Index FTSE 250

Vectura Group Key Numbers

Latest Share Price (p) 172.00 Net Gearing (%) -6.27
Market Capitalisation (£m) 717.61 Gross Gearing (%) 24.40
Shares in issue (m) 410.53 Debt Ratio 10.20
P/E Ratio 194.22 Debt-to-Equity Ratio 0.35
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.32
Dividend Yield (%) 0.00 Price to book value 3.23
Dividend cover (x) 0.00 ROCE (%) -2.51
Earning per share (p) 0.90 EPS Growth (%) 228.57
52 week high / low 200.00 / 145.30 DPS Growth (%) n/a

Vectura Group Director Deals

Dec.Date Type Director Pos No. of Shares
05/10/2015 TIN Dr Trevor Phillips ED 205,329
07/07/2015 BUY Dr Trevor Phillips ED 1,000
07/07/2015 BUY Andrew Oakley FD 1,000
17/04/2015 EXR Dr Christopher Blackwell RES 18,987
16/01/2015 EXR Dr Trevor Phillips ED 3,133

More Vectura Group Director Deals >>

Vectura Group Company News

14:07 29/04/2016

Form 8.5 (EPT/RI) - Vectura Group PLC REPLACEMENT

/* */ RNS Number : 8694W Peel Hunt LLP 29 April 2016   AMENDMENT                             FORM 8.5 (EPT/RI)  ...

12:00 29/04/2016

Form 8.5 (EPT/RI) - Skyepharma Plc

/* */ RNS Number : 7849W Peel Hunt LLP 29 April 2016    FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")...

12:00 29/04/2016

Form 8.5 (EPT/RI) -Vectura Group PLC

/* */ RNS Number : 7862W Peel Hunt LLP 29 April 2016    FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")...

More Vectura Group Company News >>

Register now for FREE Vectura Group company news

Vectura Group Share Price Discussions

more than 1 year ago

VECTURA (VEC)

Powered by IST's

Register now for FREE Vectura Group share price discussions